Results 141 to 150 of about 26,218 (217)

Adapting opioid therapy: real-world analysis of switching from methadone to slow-release morphine and back amid COVID-19 supply chain disruptions. [PDF]

Addict Sci Clin Pract
Barkus A, Subata E, Jakavičius H, Barkienė L, Lydekaitė E, Zdanavičius L, Likatavičius G, Širvinskienė A, Baltrūnienė V.   +8 more
europepmc   +1 more source

Lowering the Threshold. Models of Accessible Methadone and Buprenorphine Treatment [PDF]

, 2010
Keeney, Elizabeth, Saucier, Roxanne
core  

Found in translation: orexin receptor antagonism for the treatment of opioid use disorder. [PDF]

Transl Psychiatry
Raymond JS, Vareed RD, Peters J, James MH.   +3 more
europepmc   +1 more source

Opioid prescribing in Canada: a continued retreat from God's own medicine. [PDF]

CMAJ
Juurlink DN.
europepmc   +1 more source

From morphine to buprenorphine - Modeling opioid use disorder and its treatment during pregnancy: Effects on maternal care and offspring neurodevelopment in a translational rodent model. [PDF]

Pharmacol Biochem Behav
Richardson LM, Myers AM, Duran J, Patel DK, Tran KL, Walsh ER, Perrine SA, Bowen SE, Brummelte S.   +8 more
europepmc   +1 more source

Crosstalk Between Glycinergic and N-Methyl-D-Aspartate Receptor-Mediated Glutamatergic Transmission in Behaviours Associated with Opioid Use Disorder. [PDF]

Int J Mol Sci
Essmat N, Boldizsár I, Chalabiani Y, Varga BT, Abbood SK, Kirchlechner-Farkas JM, Király K, Miklya I, Gyertyán I, Tábi T, Fürst S, Harsing LG, Zádor F, Al-Khrasani M.   +13 more
europepmc   +1 more source

Evidence of heterogeneity in the opioid withdrawal syndrome: Spontaneous and precipitated withdrawal. [PDF]

Pharmacol Biochem Behav
Martinez S, Jones JD, Dunn KE, Huhn A, Lile JA, Shellenberg TP, Brandt L.   +6 more
europepmc   +1 more source

The role of carotid bodies in opioid-induced respiratory depression. [PDF]

Am J Physiol Lung Cell Mol Physiol
Spiller PF, Amorim MR, Polotsky VY.
europepmc   +1 more source